SEARCH:   Advanced

Blood, 15 January 2007, Vol. 109, No. 2, pp. 632-642. Prepublished online as a Blood First Edition Paper on September 19, 2006; DOI 10.1182/blood-2006-01-028423. This Article Full Text Full Text (PDF) All Versions of this Article: blood-2006-01-028423v1 109/2/632    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Cosentino, M. Articles by Lecchini, S. Search for Related Content PubMed PubMed Citation Articles by Cosentino, M. Articles by Lecchini, S. Related Collections Signal Transduction Gene Expression Immunobiology Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  IMMUNOBIOLOGY Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop Marco Cosentino1,2,, Anna Maria Fietta3, Marco Ferrari1, Emanuela Rasini1, Raffaella Bombelli1, Elena Carcano1, Federica Saporiti1, Federica Meloni3, Franca Marino1,2, and Sergio Lecchini1,2 1 Department of Clinical Medicine, Section of Experimental and Clinical Pharmacology, 2 Center for Research in Neuroscience, University of Insubria, Varese, Italy; 3 Department of Hematological, Pneumological, and Cardiovascular Sciences, University of Pavia, Italy CD4+CD25+ regulatory T lymphocytes (Tregs) are specialized T cells playing a key role in the control of immune homeostasis. Here, we show that human Tregs constitutively express tyrosine hydroxylase (TH, EC 1.14.16.2 [EC] ), the rate-limiting enzyme in the synthesis of catecholamines, and contain substantial amounts of dopamine, norepinephrine, and epinephrine, which are released upon treatment with reserpine. Catecholamine release results in reduced production of interleukin-10 and transforming growth factor-ß by Tregs, and in down-regulation of Treg-dependent inhibition of effector T-lymphocyte (Teff) proliferation, which occurs without affecting the production of tumor necrosis factor- or interferon-. Tregs and Teffs express on the cell membrane both D1-like and D2-like dopaminergic receptors to a similar extent (12%-29% of the cells). Catecholamine-dependent down-regulation of Tregs is, however, selectively reversed by pharmacological blockade of dopaminergic D1-like receptors, which in Tregs only (and not in Teffs) are also expressed at the level of mRNA and are functionally coupled to intracellular production of cAMP. These findings indicate that in human Tregs endogenous catecholamines subserve an autocrine/paracrine loop involving dopaminergic pathways and resulting in down-regulation of Treg function. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

	Blood Online is supported in part by Genentech BioOncology and Biogen Idec
	Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020